Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial
萘莫司他治疗中重度 COVID-19 肺炎住院患者:一项随机 II 期临床试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2021.101169
Zhuravel, Sergey V; Khmelnitskiy, Oleg K; Burlaka, Oleg O; Gritsan, Alexey I; Goloshchekin, Boris M; Kim, Seieun; Hong, Ka Young